vimarsana.com

Latest Breaking News On - Hedeker wealth - Page 1 : vimarsana.com

Proquility Private Wealth Partners LLC Purchases Shares of 49,581 SPDR Portfolio Long Term Treasury ETF (NYSEARCA:SPTL)

Proquility Private Wealth Partners LLC acquired a new position in shares of SPDR Portfolio Long Term Treasury ETF (NYSEARCA:SPTL – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 49,581 shares of the company’s stock, valued at approximately $1,439,000. Several other institutional […]

Royal Harbor Partners LLC Has $13 18 Million Stock Holdings in SPDR Blackstone High Income ETF (BATS:HYBL)

Royal Harbor Partners LLC raised its position in SPDR Blackstone High Income ETF (BATS:HYBL – Free Report) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 468,520 shares of the company’s stock after purchasing an additional 17,525 shares during the quarter. SPDR […]

Beacon Harbor Wealth Advisors Inc Invests $1 24 Million in SPDR Blackstone High Income ETF (BATS:HYBL)

Beacon Harbor Wealth Advisors Inc. purchased a new position in shares of SPDR Blackstone High Income ETF (BATS:HYBL – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 44,142 shares of the company’s stock, valued at approximately $1,242,000. A […]

Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)

Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research report issued on Tuesday, Benzinga reports. They presently have a $50.00 target price on the stock. Needham & Company LLC’s target price suggests a potential upside of 70.94% from the company’s […]

Harmony Biosciences Holdings, Inc (NASDAQ:HRMY) Receives $40 63 Consensus PT from Analysts

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12-month price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.